Filing Flows › Companies › agilon health › Timeline
agilon health stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+550.6% to $113.39
agilon health (AGL) stock rose 551% over the last 252 sessions, to $113.39. On the way it reported 4 quarters, its insiders filed 2 open-market trades, and the company filed 5 material 8-Ks. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Nov 4, 2026 | Earnings | Earnings: beat the EPS estimate by 384.8% | +9.2% (+7.5% vs SPY) | — | — |
| Aug 5, 2026 | Earnings | Earnings: beat the EPS estimate by 691.5% | +12.9% (+13.1% vs SPY) | −9.3% (−9.2% vs SPY) | −8.1% (−7.3% vs SPY) |
| Jul 22, 2026 | 8-K | Directors and officers: departures, appointments, pay | −17.9% (−16.6% vs SPY) | −25.7% (−23.3% vs SPY) | −25.7% (−27.7% vs SPY) |
| May 6, 2026 | Earnings | Earnings: beat the EPS estimate by 150.0% | +4.1% (+2.7% vs SPY) | +95.6% (+93.6% vs SPY) | +127.0% (+122.5% vs SPY) |
| Apr 27, 2026 | 8-K | Directors and officers: departures, appointments, pay | +9.7% (+10.2% vs SPY) | +6.2% (+5.8% vs SPY) | +127.1% (+122.3% vs SPY) |
| Mar 2, 2026 | Insider buy | Shaker Benjamin bought $7.7M | +4.5% (+4.4% vs SPY) | +1.5% (+3.5% vs SPY) | −60.7% (−52.8% vs SPY) |
| Feb 25, 2026 | Earnings | Earnings: missed the EPS estimate by -30.7% | +23.8% (+23.0% vs SPY) | +36.4% (+37.4% vs SPY) | +8.0% (+12.3% vs SPY) |
| Feb 12, 2026 | 8-K | Material definitive agreement | −0.5% (−0.6% vs SPY) | +18.8% (+17.6% vs SPY) | +49.4% (+51.2% vs SPY) |
| Jan 7, 2026 | 8-K | Directors and officers: departures, appointments, pay | +14.6% (+14.6% vs SPY) | +21.6% (+21.5% vs SPY) | −18.7% (−18.8% vs SPY) |
| Nov 12, 2025 | Insider buy | Wulf John William bought $1.3M | +1.4% (+1.4% vs SPY) | −12.2% (−8.8% vs SPY) | +15.3% (+14.4% vs SPY) |
| Nov 7, 2025 | 8-K | Delisting notice or listing-rule failure | −4.4% (−4.5% vs SPY) | −14.7% (−14.9% vs SPY) | −0.4% (−2.4% vs SPY) |
Insiders’ record here
In the year on the chart, agilon health's insiders reported 2 open-market buys ($9.0M) and 0 sales ($0). Of the 2 old enough to score, 1 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was +490.4% and after a sale —.
Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 3.01 Delisting notice or listing-rule failure | 492 | 0.0% | 46% | −0.2% | ±2.1% |
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
| 1.01 Material definitive agreement | 23,525 | 0.0% | 51% | +1.0% | ±1.4% |
| 2.03 New debt or off-balance-sheet obligation | 13,268 | 0.0% | 50% | +1.2% | ±1.3% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Report card: every quarter against the estimate → agilon health: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.